Novel EAAT2 activators improve motor and cognitive impairment in a transgenic model of Huntington's disease.

Bhatnagar, Akanksha; Parmar, Visha; Barbieri, Nicholas; Bearoff, Frank; Elefant, Felice; Kortagere, Sandhya.

Afiliação

Bhatnagar A; Department of Biology, Papadakis Integrated Sciences Building, Drexel University, Philadelphia, PA, United States.
Parmar V; Department of Biology, Papadakis Integrated Sciences Building, Drexel University, Philadelphia, PA, United States.
Barbieri N; Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, United States.
Bearoff F; Department of Biology, Papadakis Integrated Sciences Building, Drexel University, Philadelphia, PA, United States.
Elefant F; Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, United States.
Kortagere S; Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, United States.

Front Behav Neurosci ; 17: 1176777, 2023.

Article em En | MEDLINE | ID: mdl-37351153